Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Filtrar resultados de búsqueda
Seleccionar modelos de datos

Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

380 Resultados de la búsqueda.

Eligibility Leukemia NCT00058799

- 15/3/21 - 1 formulario, 2 itemgroups, 19 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine; ODM derived from: https://clinicaltrials.gov/show/NCT00058799

AML Discharge Letter Example V UKM

- 15/3/21 - 1 formulario, 13 itemgroups, 43 items, 1 idioma

Itemgroups: Administrative Data, Diagnosis, Secondary Diagnoses, Allergies, Therapy and course of disease, Current reason for presentation, Medical History, Physical Examination, Lab Results, Apparative Diagnostics, Inpatient Treatment, Medication List, Procedures

AML Discharge Letter Example V UKM provided by PD Schliemann.

Eligibility Leukemia NCT02272777

- 25/6/20 - 1 formulario, 2 itemgroups, 17 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase; ODM derived from: https://clinicaltrials.gov/show/NCT02272777

Eligibility Leukemia NCT02193100

- 25/6/20 - 1 formulario, 2 itemgroups, 15 items, 1 idioma

Itemgroups: Criteria, Exclusion Criteria

Pre and Post Treatment Metabolomic Analysis of Leukemia: A Translational Clinical Trial of the Brown Cancer Center; ODM derived from: https://clinicaltrials.gov/show/NCT02193100

Eligibility Leukemia NCT02188706

- 25/6/20 - 1 formulario, 2 itemgroups, 12 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

A Leukemia SPORE Phase II Clinical Trial Comparing Decitabine Versus Decitabine/Carboplatin and Decitabine/Arsenic for the Treatment of Relapsed, Refractory, and Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS); ODM derived from: https://clinicaltrials.gov/show/NCT02188706

Eligibility Leukemia NCT02126553

- 25/6/20 - 1 formulario, 2 itemgroups, 19 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Lenalidomide Maintenance With High Risk (HR) Acute Myeloid Leukemia (AML) in Remission; ODM derived from: https://clinicaltrials.gov/show/NCT02126553

Eligibility Leukemia NCT02096055

- 24/6/20 - 1 formulario, 2 itemgroups, 15 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

4-Arm Phase II Study of SGI-110 in Elderly Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT02096055

Eligibility Leukemia NCT02096042

- 24/6/20 - 1 formulario, 2 itemgroups, 24 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT02096042

Eligibility Leukemia NCT02028039

- 24/6/20 - 1 formulario, 2 itemgroups, 12 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT02028039

Eligibility Leukemia NCT01893320

- 24/6/20 - 1 formulario, 2 itemgroups, 14 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT01893320

Eligibility Leukemia NCT01891981

- 23/6/20 - 1 formulario, 2 itemgroups, 23 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Phase I/II Study of Moxetumomab; ODM derived from: https://clinicaltrials.gov/show/NCT01891981

Eligibility Leukemia NCT01786343

- 23/6/20 - 1 formulario, 2 itemgroups, 8 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01786343

Utilice este formulario para comentarios, preguntas y sugerencias.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.